product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human Total beta-Catenin DuoSet IC ELISA
catalog :
DYC1329-2
quantity :
1 Kit (for 2 Plates) (also 1 Kit (for 5 Plates), 1 Pack (for 15 Plates))
price :
475 USD
more info or order :
citations: 10
Reference
Al Salam S, Jagadeesh G, Sudhadevi M, Yasin J. Galectin-3 and Autophagy in Renal Acute Tubular Necrosis. Int J Mol Sci. 2024;25: pubmed publisher
Shailesh H, Siveen K, SIF S. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3. J Cell Mol Med. 2021;25:1583-1600 pubmed publisher
Clough B, Zeitouni S, Krause U, Chaput C, Cross L, Gaharwar A, et al. Rapid Osteogenic Enhancement of Stem Cells in Human Bone Marrow Using a Glycogen-Synthease-Kinase-3-Beta Inhibitor Improves Osteogenic Efficacy In Vitro and In Vivo. Stem Cells Transl Med. 2018;7:342-353 pubmed publisher
Akbarzadeh L, Moini Zanjani T, Sabetkasaei M. Comparison of Anticancer Effects of Carbamazepine and Valproic Acid. Iran Red Crescent Med J. 2016;18:e37230 pubmed publisher
Umbreit C, Flanjak J, Weiss C, Erben P, Aderhold C, Faber A, et al. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression. Anticancer Res. 2014;34:7061-9 pubmed
Takei Y, Takigahira M, Mihara K, Tarumi Y, Yanagihara K. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Cancer Res. 2011;71:1442-53 pubmed publisher
Gunn W, Krause U, Lee N, Gregory C. Pharmaceutical inhibition of glycogen synthetase kinase-3? reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model. Blood. 2011;117:1641-51 pubmed publisher
Matushansky I, Hernando E, Socci N, Mills J, Matos T, Edgar M, et al. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest. 2007;117:3248-57 pubmed
Bhattacharyya S, Borthakur A, Dudeja P, Tobacman J. Carrageenan reduces bone morphogenetic protein-4 (BMP4) and activates the Wnt/beta-catenin pathway in normal human colonocytes. Dig Dis Sci. 2007;52:2766-74 pubmed
Dolled Filhart M, McCabe A, Giltnane J, Cregger M, Camp R, Rimm D. Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res. 2006;66:5487-94 pubmed
image
image 1 :
R&D Systems DYC1329-2 image 1
product information
master code :
DYC1329-2
SKU :
DYC1329-2
product name :
Human Total beta-Catenin DuoSet IC ELISA
unit size :
1 Kit (for 2 Plates) (also 1 Kit (for 5 Plates), 1 Pack (for 15 Plates))
description :
The Human Total beta-Catenin DuoSet IC ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human beta-Catenin.
target :
beta-Catenin
category :
ELISAs
species :
Human
gene symbol :
CTNNB1
kit type :
Solid Phase Sandwich ELISA
assay length :
4 hours 40 mins (after plate preparation)
elisaRange :
312.00 - 20000 pg/mL
applications :
ELISA
USD :
475 USD
alt names :
bCatenin, beta 1 (88kD), beta-catenin, catenin (cadherin-associated protein), beta 1, 88kDa, catenin beta-1, CTNNB, CTNNB1, DKFZp686D02253, FLJ25606, FLJ37923
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.